Crystal modification A of 1-(2,6-difluorobenzyI)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof
作者： Martin Szelagiewicz , Robert Portmann , Walter Scherrer , Urs Christoph Hofmeier , Andreas Burkhard
DOI:
关键词:
摘要: The invention relates to dosage forms and formulations comprising the novel crystal modification A of compound I-(2,6-difluorobenzyl)-I H-I,2,3-triazole-4-carboxamide, wherein is characterized by characteristic lines with interplanar spacings (d values) 10.5 Å, 5.14 4.84 4.55 4.34 4.07 3.51 3.48 3.25 3.19 3.15 3.07 2.81 determined means an X-ray powder pattern. Dosage H-I,2,3-triazole-4-carboxamide may be for oral or parenteral administration, in form a solid liquid, range 20 mg less than 500 mg. Solid comprise tablet capsule, further pharmaceutically-acceptable carrier film-coat.
lens.org 参考文章(17)
Wing K. Cheung, Farid Kianifard, Audrey Wong, Josette Mathieu, Terry Cook, Vivian John, Elliot Redalieu, Keith Chan, Intra- and Inter-Subject Variabilities of CGP 33101 after Replicate Single Oral Doses of Two 200-mg Tablets and 400-mg Suspension Pharmaceutical Research. ,vol. 12, pp. 1878- 1882 ,(1995) , 10.1023/A:1016275402723
Gerard Charles Sanz, Marc Gaston Venet, Eddy Jean Edgard Freyne, Alfons Herman Margaretha Raeymaekers, (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives ,(1989)
Martin Szelagiewicz, Robert Portmann, Walter Scherrer, Urs Christoph Hofmeier, Andreas Burkhard, Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic ,(1998)
Sui Xiong Cai, Eckard Weber, John F. W. Keana, Sunil Kher, Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists ,(1994)
John Haleblian, Walter McCrone, Pharmaceutical Applications of Polymorphism Journal of Pharmaceutical Sciences. ,vol. 58, pp. 911- 929 ,(1969) , 10.1002/JPS.2600580802
Frank J.J. Leusen, Ab initio prediction of polymorphs Journal of Crystal Growth. ,vol. 166, pp. 900- 903 ,(1996) , 10.1016/0022-0248(96)00099-1
M.C. Rouan, C. Souppart, L. Alif, D. Moes, J.B. Lecaillon, J. Godbillon, Automated analysis of a novel anti-epileptic compound, CGP 33 101, and its metabolite, CGP 47 292, in body fluids by high-performance liquid chromatography and liquid-solid extraction Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 667, pp. 307- 313 ,(1995) , 10.1016/0378-4347(95)00026-F
Allen R. Kraska, B. Kenneth Koe, Charles A. Harbert, Willard M. Welch, Antidepressant derivatives of cis-4-phenyl- 1,2,3,4-tetrahydro-1-naphthalenamine ,(1979)
Charles Eric Mowbray, Alan Stobie, Quinoxaline derivatives useful in therapy ,(1997)